Labcorp Cash on Hand 2010-2023 | LH

Labcorp cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Labcorp cash on hand for the quarter ending December 31, 2023 was $0.537B, a 67.44% increase year-over-year.
  • Labcorp cash on hand for 2023 was $0.537B, a 67.44% increase from 2022.
  • Labcorp cash on hand for 2022 was $0.321B, a 78.23% decline from 2021.
  • Labcorp cash on hand for 2021 was $1.473B, a 11.5% increase from 2020.
Labcorp Annual Cash on Hand
(Millions of US $)
2023 $537
2022 $321
2021 $1,473
2020 $1,321
2019 $338
2018 $427
2017 $317
2016 $434
2015 $716
2014 $580
2013 $404
2012 $467
2011 $159
2010 $231
2009 $149
Labcorp Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $537
2023-09-30 $728
2023-06-30 $1,931
2023-03-31 $394
2022-12-31 $321
2022-09-30 $410
2022-06-30 $1,069
2022-03-31 $1,234
2021-12-31 $1,473
2021-09-30 $2,037
2021-06-30 $1,963
2021-03-31 $1,891
2020-12-31 $1,321
2020-09-30 $667
2020-06-30 $557
2020-03-31 $324
2019-12-31 $338
2019-09-30 $361
2019-06-30 $265
2019-03-31 $349
2018-12-31 $427
2018-09-30 $893
2018-06-30 $221
2018-03-31 $362
2017-12-31 $317
2017-09-30 $409
2017-06-30 $300
2017-03-31 $366
2016-12-31 $434
2016-09-30 $568
2016-06-30 $640
2016-03-31 $696
2015-12-31 $716
2015-09-30 $713
2015-06-30 $619
2015-03-31 $446
2014-12-31 $580
2014-09-30 $576
2014-06-30 $480
2014-03-31 $339
2013-12-31 $404
2013-09-30 $174
2013-06-30 $111
2013-03-31 $186
2012-12-31 $467
2012-09-30 $466
2012-06-30 $124
2012-03-31 $130
2011-12-31 $159
2011-09-30 $86
2011-06-30 $119
2011-03-31 $195
2010-12-31 $231
2010-09-30 $97
2010-06-30 $104
2010-03-31 $172
2009-12-31 $149
2009-09-30 $127
2009-06-30 $227
2009-03-31 $373
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $17.372B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
West Pharmaceutical Services (WST) United States $28.373B 47.97
Cardinal Health (CAH) United States $25.885B 15.56
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
Merit Medical Systems (MMSI) United States $4.272B 24.44
STAAR Surgical (STAA) United States $2.521B 79.39
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00